Keyphrases
Pediatric
100%
Immunization
100%
Pediatric Transplantation
100%
Pediatric Donor
80%
Vaccine Effectiveness
60%
Vaccine-preventable Diseases
60%
Hematopoietic Cell Transplantation
60%
Recombinant
40%
Vaccination
20%
Monoclonal Antibody
20%
Clinical Outcomes
20%
Infection Risk
20%
Immunogenicity
20%
Clinical Trials
20%
High Dose
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Higher-valency
20%
Knowledge Gaps
20%
Transplant Recipients
20%
Cell-mediated Immune Response
20%
Evidence Support
20%
Next-generation Vaccines
20%
Prevention Strategies
20%
Zoster
20%
Growing Population
20%
Hepatitis B
20%
Solid Organ
20%
Vaccine Trial
20%
Varicella
20%
Vaccine Formulation
20%
Safety Efficacy
20%
Underutilization
20%
Immunocompromised children
20%
New Biologics
20%
Protective Immunity
20%
Safety Effectiveness
20%
Inactivated Influenza Vaccine
20%
Vaccine Safety
20%
Immunization Strategy
20%
Vaccine Evaluation
20%
Vaccine Immunogenicity
20%
Vaccine Recommendations
20%
Immunosuppression Regimen
20%
Enhanced Immunogenicity
20%
Meningitis Vaccine
20%
Live-attenuated Viral Vaccine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Diseases
100%
Clinical Trial
66%
Clinical Study
33%
Infection
33%
Monoclonal Antibody
33%
Biological Product
33%
Live Attenuated Influenza Vaccine
33%
Hepatitis B
33%
Virus Vaccine
33%
Chickenpox
33%
Herpes Zoster
33%
Vaccine Efficacy
33%
Meningitis Vaccine
33%
Medicine and Dentistry
Pediatrics
100%
Cell Transplantation
40%
Hematopoietic Cell
40%
Diseases
30%
Clinical Trial
20%
Immunogenicity
20%
Infection
10%
Drug Megadose
10%
Clinical Study
10%
Immunosuppressive Treatment
10%
Monoclonal Antibody
10%
Virus Vaccine
10%
Cellular Immunity
10%
Influenza Vaccine
10%
Vaccine Efficacy
10%
Biological Product
10%
Disseminated Herpes Zoster
10%
Hepatitis B
10%
Chickenpox
10%
Respiratory Syncytial Virus
10%
Vaccine Immunogenicity
10%
Meningitis Vaccine
10%